We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.22B
AUM Growth
-$194M
(-3%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$18M |
| 2 |
Monro
MNRO
|
+$15.1M |
| 3 |
Dentsply Sirona
XRAY
|
+$14.8M |
| 4 |
Hubbell
HUBB
|
+$12.1M |
| 5 |
Northern Trust
NTRS
|
+$8.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$31.3M |
| 2 |
W.W. Grainger
GWW
|
+$26.8M |
| 3 |
Verizon
VZ
|
+$21.9M |
| 4 |
IPG Photonics
IPGP
|
+$18.2M |
| 5 |
Coherent Inc
COHR
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.36% |
| 2 | Healthcare | 17.82% |
| 3 | Technology | 14.53% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Revvity
RVTY
$17.3B
| $4.4M | 0.07% |
+64,523
| New | +$4.01M |
2017 Q2
0 quarters
|
|
227
Edison International
EIX
$21.4B
| $4.38M | 0.07% |
56,085
+300
| +0.5% | +$24K |
2015 Q1
9 quarters
|
|
228
GE Aerospace
GE
$324B
| $4.34M | 0.07% |
33,527
+1,222
| +4% | +$167K |
2013 Q2
16 quarters
|
|
229
AT&T
T
$161B
| $4.21M | 0.07% |
147,662
+5,872
| +4% | +$173K |
2013 Q2
16 quarters
|
|
230
Honeywell
HON
$66.7B
| $4.13M | 0.07% |
34,284
+714
| +2% | +$84.2K |
2013 Q2
16 quarters
|
|
231
Ecolab
ECL
$81.5B
| $4.08M | 0.07% |
30,712
+950
| +3% | +$123K |
2013 Q2
16 quarters
|
|
232
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $3.99M | 0.06% |
49,870
-251
| -0.5% | -$20.1K |
2013 Q2
16 quarters
|
|
233
Ametek
AME
$57B
| $3.95M | 0.06% |
65,225
+1,775
| +3% | +$105K |
2013 Q2
16 quarters
|
|
234
Novartis
NVS
$286B
| $3.77M | 0.06% |
50,399
+1,340
| +3% | +$95K |
2013 Q2
16 quarters
|
|
|
235
Verizon
VZ
$184B
| $3.62M | 0.06% |
81,090
-470,261
| -85% | -$21.9M |
2013 Q2
16 quarters
|
|
236
Kimberly-Clark
KMB
$34.6B
| $3.56M | 0.06% |
27,544
| – | – |
2013 Q2
16 quarters
|
|
237
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $3.54M | 0.06% |
86,829
+3,625
| +4% | +$147K |
2013 Q2
16 quarters
|
|
238
Vanguard FTSE Europe ETF
VGK
$29.7B
| $3.53M | 0.06% |
64,100
+2,000
| +3% | +$109K |
2013 Q2
16 quarters
|
|
239
Mondelez International
MDLZ
$80.4B
| $3.49M | 0.06% |
80,709
-675
| -0.8% | -$30.4K |
2013 Q2
16 quarters
|
|
240
Hyatt Hotels
H
$15.9B
| $3.26M | 0.05% |
57,985
+17,785
| +44% | +$1.01M |
2017 Q1
1 quarter
|
|
241
Phillips 66
PSX
$115B
| $3.25M | 0.05% |
39,306
-1,649
| -4% | -$129K |
2013 Q2
16 quarters
|
|
242
SAP
SAP
$260B
| $3.22M | 0.05% |
30,800
| – | – |
2013 Q2
16 quarters
|
|
243
Royal Bank of Canada
RY
$272B
| $3.19M | 0.05% |
44,000
| – | – |
2013 Q3
15 quarters
|
|
244
Realty Income
O
$52.6B
| $3.16M | 0.05% |
59,108
+19,660
| +50% | +$1.09M |
2016 Q4
2 quarters
|
|
245
Hasbro
HAS
$13.9B
| $3.16M | 0.05% |
28,314
+39
| +0.1% | +$4.02K |
2013 Q2
16 quarters
|
|
246
Vanguard S&P 500 ETF
VOO
$1.05T
| $3.15M | 0.05% |
14,161
+700
| +5% | +$154K |
2016 Q2
4 quarters
|
|
247
Pfizer
PFE
$168B
| $3.1M | 0.05% |
97,224
+2,789
| +3% | +$88K |
2013 Q2
16 quarters
|
|
248
iShares Russell 2000 ETF
IWM
$77.5B
| $3.08M | 0.05% |
+21,848
| New | +$3.02M |
2017 Q2
0 quarters
|
|
249
Moody's
MCO
$83.8B
| $3.08M | 0.05% |
25,275
-17,565
| -41% | -$2.06M |
2013 Q2
16 quarters
|
|
250
Canadian National Railway
CNI
$72.9B
| $3.02M | 0.05% |
37,300
| – | – |
2013 Q3
15 quarters
|
|
Similar funds
Boston Trust Walden's Q2 2017 Portfolio in Review
As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.
- Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
- Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
- Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
- Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
- Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
- Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
- Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.
Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.